Nuclear medicine firm UltraSPECT has inked a multiyear distribution agreement with nuclear pharmacy network UPPI for exclusive leasing and/or nonexclusive sale of its cardiac and bone imaging applications in the U.S..
UPPI represents more than 150 nuclear medicine operating sites across the U.S. The company and its network of nuclear pharmacies provide the national coverage needed to service large group purchasing organizations and local facilities, according to UltraSPECT.
